Reuters/ New Delhi
India celebrated the milestone of administering 1bn Covid-19 vaccine doses yesterday, with the government promoting the achievement in a song and video even as a recent drop in inoculations worries healthcare providers.
After a slow beginning in the middle of January, India’s immunisation campaign has covered three-quarters of its 944mn adults with at least one dose but only 31% with two.
The government wants all adults to get vaccinated this year.
“India scripts history,” Prime Minister Narendra Modi said on Twitter. “We are witnessing the triumph of Indian science, enterprise and collective spirit of (1.3bn) Indians.”
Modi marked the occasion by interacting with healthcare workers and a security guard at a government hospital in New Delhi.
The health ministry announced musical and other programmes across the country, and special illuminations of national monuments including a colonial-era jail.
Nearly 90% of the vaccines administered in India have come from the Serum Institute of India (SII), which produces a licensed version of the AstraZeneca drug.
SII has more than tripled its capacity since April and can now produce 220mn vaccine doses a month.
SII has also slowly resumed exports for the first time since April, when the government stopped all overseas sales to meet domestic demand as infections rose dramatically.
The World Health Organisation (WHO), which relies heavily on India for supplies to its global vaccine-sharing platform Covax, congratulated the country for reaching the landmark.
“India’s progress must be viewed in the context of the country’s commendable commitment and efforts to ensure that these life-saving vaccines are accessible globally,” said Poonam Khetrapal Singh, regional director WHO South-East Asia.
Covax partner Unicef also congratulated India and said it looked forward to “hearing details about the expected timeline and volumes of supplies to be made” to the global facility.
The media last week reported that India has delayed supplies of the AstraZeneca vaccine to Covax.
New Delhi has been annoyed by the WHO’s repeated delay in adding India’s own Covaxin shot to the world body’s emergency-use listing, something both parties discussed this week as well as exports.
LEAVE A COMMENT Your email address will not be published. Required fields are marked*
India reports first Omicron cases, no plan for boosters
India says Omicron shows up on tests, advises states to ramp up checks
Malabar Gold & Diamonds launches its first Artistry Concept Store in India
AFP/ Burhanpur, India
India set to begin overseas flights, tightens Covid variant screening
India to resume schedule international passenger flights on Dec 15
Indian builds Taj Mahal replica home for wife
Indian farmers reinforce protest sites to mark year of demonstrations
Fall in Covid-testing worries India officials